Book Value per Share: Q32 Bio (QTTB)
Q32 Bio Inc. is developing innovative therapies for severe immune pathologies with immense potential for global expansion. The absolute book value per share reflects a trend of real asset accumulation, while the current status is 4.45. Partnerships with global behemoths minimize R&D expenses, driving FCF growth, while the uniqueness of clinical data protects future market share from competition.
Q32 Bio Inc - analytical breakdowns and key metrics (QTTB)
- price and consensus price forecast:
- market capitalization data:
- book capitalization data:
- debt and liquidity data:
Fundamental company valuation:q32bio.com - QTTB
To find a fundamental floor, it is essential for an investor to evaluate the company's residual capital net of all liabilities. By analyzing the book value per share, one can determine the extent to which the implementation of robotic dosing systems and data validation automation at Q32 Bio Inc. (QTTB) are being capitalized into tangible assets, creating a necessary margin of safety and protecting the investment value from systemic business degradation.
Competitors of Q32 Bio Inc. (QTTB)
Accounting Value per Share Argenx ARGX|BNTX - Book Price of a Share|Abivax Corp (ABVX) - Book Value per Share|ADMA (admabiologics.com) - Net Assets per Single Share|Net Assets per Single Share Protagonist PTGX|Share Book Value Immunovant Inc|Kiniksa Pharmaceuticals Ltd (KNSA) - Book Value per Share|Accounting Value of a Share Grifols Biemat (GRFS)|Book Value per Share ADPT (Adaptive Biotechnologies)|celldex.com - Book Value per Share|Net Assets per Single Share Aurinia Pharmaceuticals Inc. (AUPH)|BCRX: Accounting Value of a Share|VERA (Vera Pharma) - Net Assets per Single Share|Dianthus Corp (DNTH) - Accounting Value per Share|PHVS (Pharvaris N.V.) - Book Value per Share|Book Value per Share AbCellera Corp (ABCL)|Tourmaline Bio (TRML) - Accounting Value per Share|Accounting Value of a Share Precigen Inc (PGEN)|Book Value per Share PHAR|Nektar Corp - Net Assets per Share|UPB: Net Assets per Single Share|ZBIO: Accounting Value per Share|IMNM (Immunome) - Net Assets per Single Share|Accounting Value per Share Gossamer Bio Inc|KALV (KalVista Pharmaceuticals Inc) - Accounting Value per Share|Book Value per Share SEPN|Net Assets per Single Share Pieris Pharmaceuticals PVLA|Equity per Share savarapharma.com (SVRA)|RIGL: Book Value per Share|AnaptysBio Inc - Net Asset Value per Share|Net Assets per Single Share ATXS|enGene Corp (ENGN) - Book Value of One Share|RAPT Therapeutics, Inc. (RAPT) - Accounting Value per Share|Net Assets per Single Share Aerovate Therapeutics|ACRS - Accounting Value per Share|Accounting Value of a Share Kyverna Therapeutics Inc.|Book Value per Share Tiziana Life Sciences PLC (TLSA)|Net Assets per Single Share Cabaletta Bio Inc (CABA)|Book Value per Share VTYX|theratech.com - Net Assets per Share|AVTX (Avalo Therapeutics) - Net Assets per Single Share|Eledon Pharmaceuticals Inc. (ELDN) - Net Asset Value per Share|Accounting Value per Share Agenus Inc AGEN|Climb Bio, Inc (CLYM) - Accounting Value of a Share|ZURA: Book Value per Share|Net Assets per Share ATYR|Net Assets per Single Share Adagene ADAG|Equity per Share ikenaoncology.com (IMA)|Shattuck Labs - Book Value per Share|EQ - Accounting Value per Share|Accounting Value per Share CNTB (Connect Pharma)|IMUX: Net Assets per Share|Net Assets per Single Share ATRA (atarabio.com)|Book Value of One Share InflaRx|X4 Pharma (XFOR) - Accounting Value per Share|Book Price of a Share Adicet (ACET)|Accounting Value per Share Celularity Inc.|Book Price of a Share inmunebio.com (INMB)|Book Value per Share Barinthus Biotherapeutics plc BRNS|Kezar Life Sciences Inc. - Net Assets per Single Share|Net Assets per Single Share SAB Biotherapeutics, Inc|AKTX - Share Book Value|Book Value per Share enlivex.com ENLV|geovax.com (GOVX) - Accounting Value of a Share|EDSA (Edesa Biotech) - Book Value per Share|Book Value per Share IBIO|Carisma Therapeutics (CARM) - Net Assets per Single Share|Accounting Value of a Share XTLB (XTL Bio)|Bolt Biotherapeutics, Inc. - Net Assets per Single Share|Accounting Value per Share HCW Biologics, Inc. HCWB|Aptevo - Book Value per Share|AIM ImmunoTech, Inc. (AIM) - Book Value per Share|Accounting Value per Share aditxt.com ADTX|GRI Bio Corporation (GRI) - Accounting Value of a Share|XRTX: Book Value per Share|Net Assets per Share HIND|Net Assets per Single Share REVB (Revelation Biosciences, Inc.)|Accounting Value per Share INDP (Indaptus Therapeutics Inc)|Scinai - Net Assets per Single Share|CALI - Accounting Value per Share|Affimed Therapeutics - Accounting Value per Share|ALLK: Book Value per Share|Net Assets per Single Share hookipapharma.com|IGM Biosciences (IGMS) - Equity per Share|Book Value per Share ITOS (iTeos)|Net Asset Value per Share OCEA|TCBP: Net Assets per Single Share|Book Value of One Share thirdharmonicbio.com THRD